Psoriasis and ichthyoses

Skin Moisturization

Volumn , Issue , 2002, Pages 179-201

  Ghadially, Ruby ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345186542     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24:1–23.
2. Williams ML. Lipids in normal and pathological desquamation. Adv Lipid Res 1991; 24(3):211–262.
3. Lampe MA, Williams ML, Elias PM. Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 1983; 24(2):131–140.
4. Rehfeld SJ et al. Calorimetric and electron spin resonance examination of lipid phase transitions in human stratum corneum: molecular basis for normal cohesion and abnormal desquamation in recessive X-linked ichthyosis. J Invest Dermatol 1988; 91(5):499–505.
5. Egelrud T, Hofer PA, Lundstrom A. Proteolytic degradation of desmosomes in plantar stratum corneum leads to cell dissociation in vitro. Acta Derm Venereol 1988; 68(2):93–97.
6. Williams ML, Elias PM. Genetically transmitted, generalized disorders of cornification. The ichthyoses. Dermatol Clin 1987; 5(1):155–178.
7. Swartzendruber DC, et al. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989; 92(2):251–257.
8. Hou SY, et al. Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol 1991; 96(2):215–223.
9. Fartasch M. Epidermal barrier in disorders of the skin. Microsc Res Tech 1997; 38(4):361–372.
10. Fartasch M, Williams ML, Elias PM. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 1999; 135(7):823–832.
11. Swartzendruber DC, et al. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 1987; 88(6):709–713.
12. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992; 98(3):279–289.
13. Menon GK, et al. De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res 1985; 26:418–427.
14. Grubauer G, Feingold KR, Elias PM. The relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res 1987; 28(6):746–752.
15. Holleran WM, et al. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991; 88(4):1338–1345.
16. Elias PM, Brown BE. The mammalian cutaneous permeability barrier: defective barrier function in essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest 1978; 39(6):574–583.
17. Feingold KR, et al. The effect of essential fatty acid deficiency on cutaneous sterol synthesis. J Invest Dermatol 1986; 87:588–591.
18. Christophers E, Sterry W. In: Fitzpatrick TB, Eizen AZ, Wolff K, Freedberg IM, Auskn KF, eds. Dermatology in General Medicine. New York: McGraw-Hills1993:490–514.
19. Toussaint S, Kamino H. In: Elder, DEA, ed. Lever’s Histopathology of the Skin. Philadelphia: Lippincott-Raven, 1997:151–184.
20. Bonneville MA, Weinstock M, Wilgram GF. An electron microscope study of cell adhesion in psoiatic epidermis. J Ultrastr Res 1968; 23(1):15–43.
21. Mottaz JH, Zelickson AS. Keratinosomes in psoriatic skin. Acta Derm Venereol 1975; 55(2):81–85.
22. Lupulescu AP, Chadwick JM, Downham TFD. Ultrastructural and cell surface changes of human psoriatic skin following Goeckerman therapy. J Cutan Pathol 1979; 6(5):347–363.
23. Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107(4):558–564.
24. Motta S, et al. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 1994; 130(4):452–456.
25. Baxter DL, Stoughton RB. Mitotic index of psoriatic lesions treated with anthralin, glucocorticosteriod and occlusion only. J Invest Dermatol 1970; 54(5):410–412.
26. Friedman SJ. Management of psoriasis vulgaris with a hydrocolloid occlusive dressing. Arch Dermatol 1987; 123(8):1046–1052.
27. Shore RN. Clearing of psoriatic lesions after the application of tape [letter]. N Engl J Med 1985; 312(4):246.
28. Feingold KR, et al. Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 1990; 86:1738–1745.
29. Hashimoto K, Khan S. Harlequin fetus with abnormal lamellar granules and giant mitochondria. J Cutan Pathol 1992; 19(3):247–252.
30. Menon GK, et al. Lamellar bodies as delivery systems of hydrolytic enzymes: implications for normal cohesion and abnormal desquamation. Br J Dermatol 1992; 126:337–345.
31. Ghadially R, et al. Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol 1992; 99(6):755–763.
32. Nanney LB, et al. Altered [125I] epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986; 86:260–265.
33. lder JT, et al. Overexpression of transforming growth factor a in psoriatic epidermis. Science 1989; 243:811–814.
34. Kagramanova AT, Tishchenko LD, Berezov TT. [The ornithine decarboxylase activity of the epidermis in psoriasis as a biochemical index of the hyperproliferative process]. Biulleten Eksperimentalnoi Biologii i Meditsiny 1993; 115(6):618–620.
35. Nagpal S, Athanikar J, Chandraratna RA. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha. J Biol Chem 1995; 270(2):923- 927.
36. Schroeder WT, et al. Type I keratinocyte transglutaminase: expression in human skin and psoriasis. J Invest Dermatol 1992; 99(1):27–34.
37. Bernard BA, et al. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J InvestDermatol 1988; 90(6):801–805.
38. Thewes M, et al. Normal psoriatic epidermis expression of hyperproliferation-associated keratins. Arch Dermatol Res 1991;283(7):465–471.
39. Felsher Z, Rothman S. The insensible perspiration of the skin in hyperkeratotic disorders. J Invest Dermatol 1945; 6:271–278.
40. Frost P, et al. Ichthyosiform dermatoses. 3. Studies of transepidermal water loss. Arch Dermatol 1968; 98(3):230–233.
41. Grice KA, Bettley FR. Skin water loss and accidental hypothermia in psoriasis, ichthyosis, and erythroderma. Br Med J 1967; 4(573):195–198.
42. Grice K, Sattar H, Baker H. The cutaneous barrier to salts and water in psoriasis and in normal skin. Br J Dermatol 1973; 88(5):459–463.
43. Tagami H, Yoshikuni K. Interrelationship between water-barrier and reservoir functions of pathologic stratum corneum. Arch Dermatol 1985; 121(5):642–645.
44. Wood LC, et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90(2):482–487.
45. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J AM Acad Dermatol 1994; 30:535–546.
46. Fraki JE, Briggaman RA, Lazarus GS. Transplantation of psoriatic skin onto nude mice. J Invest Dermatol 1983; 80(3) (Suppl): 31s–35s.
47. Sundberg JP, et al. Full-thickness skin grafts from flaky skin mice to nude mice: maintenance of the psoriasiform phenotype. J Invest Dermatol 1994; 102(5):781–788.
48. Saiag P, et al. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 1985; 230(4726):669–672.
49. Priestly GC, Lord R. Fibroblast-keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro. Br J Dermatol 1990; 123(4):467–472.
50. Proksch E, et al. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991; 87(5):1668–1673.
51. Wood LC, et al. Barrier function coordinately regulates epidermal IL-1 and IL-1RA mRNA levels. Exp Dermatol 1994; 3:56–60.
52. Eyre RW, Krueger GG. Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and ‘reverse’ Koebner reactions. Br J Dermatol 1982; 106(2):153–159.
53. Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 1985; 84(3):191–194.
54. Lsayed-Ali, H, Barton S, Marks R. Stereological studies of desmosomes in ichthyosis vulgaris. Br J Dermatol 1992; 126(1):24–28.
55. Nirunsuksiri W, et al. Decreased profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control. J Biol Chem 1995; 270(2):871–876.
56. Suzuki Y, et al. The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 1996; 134(3):460–464.
57. Lavrijsen AP, et al. Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol 1993; 129(5):547–553.
58. Ohman H, Vahlquist A. The pH gradient over the stratum corneum differs in X-linked recessive and autosomal dominant ichthyosis: a clue to the molecular origin of the “acid skin mantle”? J Invest Dermatol 1998; 111(4):674–677.
59. Hernandez-Martm A, Gonzalez-Sarmiento R, De Unamuno P. X-linked ichthyosis: an update. Br J Dermatol 1999; 141(4):617–627.
60. Koppe G, et al. X-linked icthyosis. A sulphatase deficiency. Arch Disease Childhood 1978; 53(10):803–806.
61. Webster D, et al. X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet 1978; 1(8055):70–72.
62. Ballabio A, et al. Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosis. Proc Natl Acad Sci USA 1987; 84(13):4519–4523.
63. Feinstein A, Ackerman AB, Ziprkowski L. Histology of autosomal dominant ichthyosis vulgaris and X-linked ichthyosis. Arch Dermatol 1970; 101(5):524- 527.
64. Mesquita-Guimaraes, J. X-linked ichthyosis. Ultrastructural study of 4 cases. Dermatologica 1981; 162(3):157–166.
65. Zettersten E, et al. Recessive X-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol 1998; 111(5):784–790.
66. Bouwstra JA, et al. Cholesterol sulfate and calcium affect stratum corneum lipid organization over a wide temperature range. J Lipid Res 1999; 40(12):2303–2312.
67. Johansen JD, et al. Skin barrier properties in patients with recessive X-linked ichthyosis. Acta Derm Venereol 1995; 75(3):202–204.
68. Vahlquist A. Ichthyosis—an inborn dryness of the skin. In: Dry Skin and Moisturizers: Chemistry and Function Boca Raton: CRC Press, 2000:121–133.
69. Yoshiike T, et al. The effect of steroid sulphatase on stratum corneum shedding in patients with X-linked ichthyosis. Br J Dermatol 1985; 113(6):641–643.
70. Lykkesfeldt G, Hoyer H. Topical cholesterol treatment of recessive X-linked ichthyosis. Lancet 1983; 2(8363):1337–1338.
71. Hohl D, Huber M, Frenk E. Analysis of the cornified cell envelope in lamellar ichthyosis [see comments]. Arch Dermatol 1993; 129(5):618–624.
72. Lavrijsen AP, et al. Reduced skin barrier function parallels abnormal stratum corneum lipid organization in patients with lamellar ichthyosis. J Invest Dermatol 1995; 105(4):619–624.
73. Huber M, et al. Lamellar ichthyosis is genetically heterogeneous—cases with normal keratinocyte transglutaminase [see comments]. J Invest Dermatol 1995; 105(5):653–654.
74. Ammirati CT, Mallory SB. The major inherited disorders of cornification. New advances in pathogenesis. Dermatol Clin 1998; 16(3):497–508.
75. Hazell M, Marks R. Clinical, histologic, and cell kinetic discriminants between lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985; 121(4):489–493.
76. Matsuki M, et al. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci USA 1998; 95(3):1044–1049.
77. Choate KA, Williams ML, Khavari PA. Abnormal transglutaminase 1 expression pattern in a subset of patients with erythrodermic autosomal recessive ichthyosis. J Invest Dermatol 1998; 110(1):8–12.
78. Williams ML, Elias PM. Heterogeneity in autosomal recessive ichthyosis. Clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985; 121(4):477–488.
79. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130(8):1026–1035.
80. Yang JM, et al. Arginine in the beginning of the 1Arod domain of the keratin 10 gene is the hot spot for the mutation in epidermolytic hyperkeratosis. J Dermatol Sci 1999; 19(2):126–133.
81. Smack DP, Korge BP, James WD. Keratin and keratinization. J AM Acad Dermatol 1994; 30(1):85–102.
82. Porter RM, et al. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol 1998; 110(6):951–957.
83. Reichelt J, et al. Normal ultrastructure, but altered stratum corneum lipid and protein composition in a mouse model for epidermolytic hyperkeratosis. J Invest Dermatol 1999; 113(3):329–334.
84. Scott IR, Harding CR, Barrett JG. Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum. Biochim Biophys Acta 1982; 719(1):110–117.
85. Steijlen PM, et al. Topical treatment of ichthyoses and Darier’s disease with 13-cis- retinoic acid. A clinical and immunohistochemical study. Arch Dermatol Res 1993; 285(4):221–226.
86. Lucker GP, et al. Oral treatment of ichthyosis by the cytochrome p-450 inhibitor liarozole. Br J Dermatol 1997; 136(1):71–75.
87. Jensen TG, et al. Correction of steroid sulfatase deficiency by gene transfer into basal cells of tissue-cultured epidermis from patients with recessive X-linked ichthyosis. Exper Cell Res 1993; 209(2):392–397.
88. Freiberg RA, et al. A model of corrective gene transfer in X-linked ichthyosis. Hum Mol Gene 1997; 6(6):927–933.
89. Gnemo A, Vahlquist A. Lamellar ichthyosis is markedly improved by a novel combination of emollients [letter]. Br J Dermatol 1997; 137(6):1017–1018.
90. Ganemo A, Virtanen M, Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double-blind study of four different cream formulations. Br J Dermatol 2000; 141(6):1027–1032.
91. Perry TB, et al. Prenatal diagnosis of congenital non-bullous ichthyosiform erythroderma (lamellar ichthyosis). Prenatal Diagnosis 1987; 7(3):145–155.
92. Akiyama M, Holbrook KA. Analysis of skin-derived amniotic fluid cells in the second trimester; detection of severe genodermatoses expressed in the fetal period. J Invest Dermatol 1994; 103(5):674–677.
93. Choate KA, et al. Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum Gene Ther 1996; 7(18):2247–2253.
94. Choate KA, et al. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 1996; 2(11):1263–1267.
95. Schorr WF, Papa CM. Epidermolytichyperkeratosis. Effect of tretinoin therapy on the clinical course and the basic defects in the stratum corneum. Arch Dermatol 1973; 107(4):556–562.
96. Holbrook KA, et al. Epidermolytic hyperkeratosis: ultrastructure and biochemistry of skin and amniotic fluid cells from two affected fetuses and a newborn infant. J Invest Dermatol 1983; 80(4):222–227.